Insider · CIK 0001257410

McKinney Robert A

CIK 0001257410 Name as filed on the most recent filing

Filed as McKinney Robert A (18)

24 transaction lines · from 18 filings · filed 2004-02-20 to 2011-06-20 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

24 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2011-06-17 S, Open-market sale Progenics Pharmaceuticals IncPGNX 22,500, disposed Open Form 4 filing 0001441844-11-000023
2010-06-18 S, Open-market sale Progenics Pharmaceuticals IncPGNX 25,000, disposed Open Form 4 filing 0001447348-10-000002
2009-06-19 S, Open-market sale Progenics Pharmaceuticals IncPGNX 26,265, disposed Open Form 4 filing 0001266375-09-000001
2007-02-12 S, Open-market sale Progenics Pharmaceuticals IncPGNX 117,908, disposed Open Form 4 filing 0001266375-07-000018
2007-01-29 S, Open-market sale Progenics Pharmaceuticals IncPGNX 118,872, disposed Open Form 4 filing 0001266375-07-000014
2007-01-16 S, Open-market sale Progenics Pharmaceuticals IncPGNX 115,160, disposed Open Form 4 filing 0001266375-07-000013
2007-01-03 S, Open-market sale Progenics Pharmaceuticals IncPGNX 102,708, disposed Open Form 4 filing 0001266375-07-000008
2006-12-11 S, Open-market sale Progenics Pharmaceuticals IncPGNX 110,988, disposed Open Form 4 filing 0001266375-06-000112
2006-11-27 S, Open-market sale Progenics Pharmaceuticals IncPGNX 112,188, disposed Open Form 4 filing 0001266375-06-000107
2006-11-13 S, Open-market sale Progenics Pharmaceuticals IncPGNX 116,124, disposed Open Form 4 filing 0001266375-06-000104
2006-11-10 S, Open-market sale Progenics Pharmaceuticals IncPGNX 112,000, disposed Open Form 4 filing 0001266375-06-000104
2006-11-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 103,856, disposed Open Form 4 filing 0001266375-06-000102
2006-10-27 S, Open-market sale Progenics Pharmaceuticals IncPGNX 104,000, disposed Open Form 4 filing 0001266375-06-000099
2006-06-20 S, Open-market sale Progenics Pharmaceuticals IncPGNX 64,239, disposed Open Form 4 filing 0001266375-06-000063
2006-02-27 S, Open-market sale Progenics Pharmaceuticals IncPGNX 45,000, disposed Open Form 4 filing 0001266375-06-000037
2005-08-01 S, Open-market sale Progenics Pharmaceuticals IncPGNX 4 lines 281,100, disposed Open Form 4 filing 0001266375-05-000005
2005-06-20 S, Open-market sale Progenics Pharmaceuticals IncPGNX 14,903, disposed Open Form 4 filing 0001125282-05-003317
2005-02-24 S, Open-market sale Progenics Pharmaceuticals IncPGNX 72,000, disposed Open Form 4 filing 0001125282-05-000992
2004-02-18 S, Open-market sale Progenics Pharmaceuticals IncPGNX 32,250, disposed Open Form 4 filing 0001125282-04-000692
2004-02-17 S, Open-market sale Progenics Pharmaceuticals IncPGNX 2 lines 129,010, disposed Open Form 4 filing 0001125282-04-000692

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 24
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. MCKINNEY ROBERT A, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001257410

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.